Stay updated on ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Sign up to get notified when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.

Latest updates to the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page
- Check2 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2. The Back to Top element was removed.SummaryDifference0.8%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.8%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific study status dates, while removing various location-related terms.SummaryDifference10%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check46 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADVENT-AML: Azacitidine/Venetoclax with NK Cells Clinical Trial page.